Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 2291166-56-6, Lacutoclax [inn], Orb2277623, Chembl5314523, Schembl22127368, Schembl30104747
Molecular Formula
C48H55ClN8O7S
Molecular Weight
923.5  g/mol
InChI Key
CCDRQWAEZGRMTP-WJOKGBTCSA-N
FDA UNII
PMG5245L91

Lacutoclax is an orally bioavailable inhibitor of the anti-apoptotic protein B-cell lymphoma 2 (Bcl-2), with potential pro-apoptotic and antineoplastic activities. Upon oral administration, lacutoclax targets, binds to and inhibits the activity of Bcl-2. This restores apoptotic processes in tumor cells. Bcl-2 is overexpressed in many cancers and plays an important role in the negative regulation of apoptosis; its expression is associated with increased drug resistance and tumor cell survival.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-2-[(12R)-12-methyl-13-oxa-2,4,10-triazatricyclo[7.4.0.03,7]trideca-1(9),2,5,7-tetraen-10-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonylbenzamide
2.1.2 InChI
InChI=1S/C48H55ClN8O7S/c1-31-29-56(44-24-34-13-17-50-45(34)52-47(44)64-31)42-25-37(55-20-18-54(19-21-55)30-35-12-16-48(2,3)27-40(35)33-4-6-36(49)7-5-33)8-10-39(42)46(58)53-65(61,62)38-9-11-41(43(26-38)57(59)60)51-28-32-14-22-63-23-15-32/h4-11,13,17,24-26,31-32,51H,12,14-16,18-23,27-30H2,1-3H3,(H,50,52)(H,53,58)/t31-/m1/s1
2.1.3 InChI Key
CCDRQWAEZGRMTP-WJOKGBTCSA-N
2.2 Other Identifiers
2.2.1 UNII
PMG5245L91
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 2291166-56-6

2. Lacutoclax [inn]

3. Orb2277623

4. Chembl5314523

5. Schembl22127368

6. Schembl30104747

7. Pmg5245l91

8. Bdbm50636460

9. Da-74871

10. Hy-156620

11. Cs-0886444

12. T79852

13. 4-{4-[(4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl]piperazin-1-yl}-2-[(3r)-3-methyl-2,3-dihydropyrrolo[3',2':5,6]pyrido[2,3-b][1,4]oxazin-1(6h)-yl]-n-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)benzamide

14. Benzamide, 4-(4-((2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl)methyl)-1-piperazinyl)-2-((3r)-2,3-dihydro-3-methylpyrrolo(3',2':5,6)pyrido(2,3-b)(1,4)oxazin-1(6h)-yl)-n-((3-nitro-4-(((tetrahydro-2h-pyran-4-yl)methyl)amino)phenyl)sulfonyl)-

2.4 Create Date
2020-08-13
3 Chemical and Physical Properties
Molecular Weight 923.5 g/mol
Molecular Formula C48H55ClN8O7S
XLogP38.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count12
Rotatable Bond Count11
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area186
Heavy Atom Count65
Formal Charge0
Complexity1790
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1